| Attributes | Values |
|---|
| rdf:type
| |
| description
| - wetenschappelijk artikel (nl)
- wüsseschaftlicher Artikel, wo im Johr 2000 veröffentlicht worden isch (gsw)
- наукова стаття, опублікована в січні 2000 (uk)
- im Jahr 2000 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en xineru de 2000 (ast)
- articolo scientifico (pubblicato il 2000) (it)
- artikull shkencor i botuar më 01 janar 2000 (sq)
- scientific article published on 01 January 2000 (en)
|
| publication date
| |
| publication date
| |
| cites work
| |
| cites work
| - A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat.
- Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant
- Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat.
- Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker
- HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat
- The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion
- Enantiomeric cannabinoids: stereospecificity of psychotropic activity
- Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist
- Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis
- Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis
- Suppression of experimental autoimmune encephalomyelitis by cannabinoids
- Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis
- HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomy
- A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects
- Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9tetrahydrocannabinol
- Follow-up study of MS patients treated with high-dose intravenous methylprednisolone
- In vitro TNF-alpha, IL-2 and IFN-gamma production as markers of relapses in multiple sclerosis.
- A novel nonpsychotropic cannabinoid, HU-211, in the treatment of experimental pneumococcal meningitis.
- Increased production of tumor necrosis factor alpha, and not of interferon gamma, preceding disease activity in patients with multiple sclerosis.
- Neuroprotective activity of HU-211, a novel NMDA antagonist, in global ischemia in gerbils
- Post-ischemic administration of HU-211, a novel non-competitive NMDA antagonist, protects against blood-brain barrier disruption in photochemical cortical infarction in rats: a quantitative study.
|
| author name string
| |
| author name string
| - A Achiron
- A Biegon
- R Margalit
- V Lavie
- S Miron
|
| rdfs:label
| - Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis (en)
- Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis (nl)
- Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis (sq)
|
| skos:prefLabel
| - Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis (en)
- Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis (nl)
- Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis (sq)
|
| name
| - Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis (en)
- Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis (nl)
- Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis (sq)
|
| title
| |
| title
| - Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1016/S0165-5728(99)00149-6
|
| is about
of | |
| is cites work
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)